Peptide Longevity Q&A ·
Research indicates that women with polycystic ovary syndrome (PCOS) have reduced levels of MOTS-c in both serum and skeletal muscle, which is associated with mitochondrial dysfunction. This suggests a potential link between MOTS-c and metabolic health in this population.
What the research shows
The study aimed to assess circulating and skeletal muscle MOTS-c levels in women diagnosed with polycystic ovary syndrome (PCOS) and to explore their associations with various metabolic and hormonal parameters. A total of 40 women with PCOS were compared to 40 age- and BMI-matched healthy controls. The researchers utilized enzyme-linked immunosorbent assay (ELISA) to quantify serum MOTS-c concentrations, while skeletal muscle MOTS-c expression was evaluated through Western blotting in biopsy specimens from the vastus lateralis muscle. The study found that women with PCOS exhibited significantly lower circulating MOTS-c concentrations compared to the control group, with a mean of 220.2 pg/mL versus 498.3 pg/mL. Additionally, skeletal muscle MOTS-c expression was also reduced in the PCOS group.
Why it matters for longevity
The findings suggest that MOTS-c may play a crucial role in mitochondrial function and metabolic health, particularly in women with PCOS, a condition often associated with insulin resistance and metabolic dysfunction. Mitochondrial-derived peptides like MOTS-c are known to regulate glucose homeostasis and skeletal muscle metabolism. The observed reductions in MOTS-c levels in women with PCOS could indicate impaired mitochondrial function, which is a key factor in aging and longevity. As mitochondrial health is linked to overall metabolic health and resilience against age-related diseases, understanding the role of MOTS-c could provide insights into potential interventions for improving healthspan and longevity.
Key findings at a glance
- Women with PCOS had lower serum MOTS-c levels compared to healthy controls (220.2 pg/mL vs. 498.3 pg/mL).
- Skeletal muscle MOTS-c expression was significantly reduced in women with PCOS.
- Serum MOTS-c levels were inversely associated with total testosterone and total cholesterol.
- The study highlights a potential link between mitochondrial dysfunction and the metabolic phenotype of PCOS.
- MOTS-c may serve as a marker for mitochondrial involvement in metabolic disorders.
How MOTS-c works (background)
MOTS-c is a mitochondrial-derived peptide that plays a role in regulating metabolic processes, including glucose metabolism and skeletal muscle function. It is believed to influence mitochondrial biogenesis and energy homeostasis. By modulating these processes, MOTS-c can impact overall metabolic health, which is particularly relevant in conditions like PCOS where mitochondrial dysfunction is evident. The peptide's ability to regulate key metabolic pathways makes it a subject of interest in research focused on aging and longevity.
Safety, caveats, and what we don't yet know
This study's findings are based on a specific population of women with PCOS, and further research is needed to determine the generalizability of these results to other populations. Additionally, while the association between reduced MOTS-c levels and metabolic dysfunction is noted, causation has not been established. Future studies should explore the mechanisms by which MOTS-c influences mitochondrial function and investigate its potential as a therapeutic target in metabolic disorders. There is also a need to understand the long-term implications of MOTS-c levels on healthspan and longevity.
Bottom line
Reduced levels of MOTS-c in women with PCOS suggest a link to mitochondrial dysfunction, potentially impacting metabolic health and longevity. Further research is warranted to explore these associations and their implications for treatment.
Related questions
Can MOTS-c improve metabolic health in aging populations?
Research indicates that mitochondrial-derived peptides like MOTS-c may enhance metabolic health by improving mitochondrial function, which is crucial for maintaining energy balance and metabolic processes as individuals age.
What role does MOTS-c play in insulin resistance?
MOTS-c has been shown to regulate glucose homeostasis, which is particularly relevant in conditions characterized by insulin resistance, such as PCOS. Its levels may reflect the metabolic state and mitochondrial health in affected individuals.
Are there therapeutic applications for MOTS-c in metabolic disorders?
Given its role in regulating metabolism and mitochondrial function, MOTS-c holds potential as a therapeutic target for metabolic disorders, warranting further investigation into its efficacy and safety in clinical settings.
Source: PubMed · Sci Rep · published 2026-02-12.